ASPHDCRISPRプラスミド
サンタクルスバイオテクノロジー社は遺伝子サイレンシング用のCRISPR/Cas9ノックアウト及びCRISPR Double Nickaseプラスミドを含め、広範囲の遺伝子編集製品を提供しております。ASPHD遺伝子サイレンサーは、ASPHD CRISPR/Cas9ノックアウトプラスミドとASPHDDouble Nickaseプラスミドとして利用可能です。遺伝子活性化用のASPHDCRISPR/dCas9 Activationプラスミド及びCRISPR Lenti Activationシステムも利用できます。遺伝子サイレンサーと活性化剤はタンパク質の検出に使用された抗体と組み合わせた遺伝子研究に有用です。
ASPHD CRISPR Knockout, HDR and Double Nickase Plasmids
| Empty Table Header | 製品名 | CATALOG # | Species | アプリケーション | MARKER | 引用文献 | レーティング |
|---|---|---|---|---|---|---|---|
ASPHD1 CRISPR/Cas9 KOプラスミド (h) | sc-415187 | h | Gene Knockout | GFP | 0 | ||
ASPHD1 HDRプラスミド (h) | sc-415187-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
ASPHD1 Double Nickaseプラスミド (h) | sc-415187-NIC | h | Gene Knockout | Puromycin | 0 | ||
ASPHD1 Double Nickaseプラスミド (h2) | sc-415187-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
ASPHD1 CRISPR/Cas9 KOプラスミド (m) | sc-433316 | m | Gene Knockout | GFP | 0 | ||
ASPHD1 HDRプラスミド (m) | sc-433316-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
ASPHD1 Double Nickaseプラスミド (m) | sc-433316-NIC | m | Gene Knockout | Puromycin | 0 | ||
ASPHD1 Double Nickaseプラスミド (m2) | sc-433316-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
ASPHD2 CRISPR/Cas9 KOプラスミド (h) | sc-408926 | h | Gene Knockout | GFP | 0 | ||
ASPHD2 HDRプラスミド (h) | sc-408926-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
ASPHD2 Double Nickaseプラスミド (h) | sc-408926-NIC | h | Gene Knockout | Puromycin | 0 | ||
ASPHD2 Double Nickaseプラスミド (h2) | sc-408926-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
ASPHD2 CRISPR/Cas9 KOプラスミド (m) | sc-428461 | m | Gene Knockout | GFP | 0 | ||
ASPHD2 HDRプラスミド (m) | sc-428461-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
ASPHD2 Double Nickaseプラスミド (m) | sc-428461-NIC | m | Gene Knockout | Puromycin | 0 | ||
ASPHD2 Double Nickaseプラスミド (m2) | sc-428461-NIC-2 | m | Gene Knockout | Puromycin | 0 |
ASPHD CRISPR Activation Products
| Empty Table Header | 製品名 | CATALOG # | Species | アプリケーション | MARKER | 引用文献 | レーティング |
|---|---|---|---|---|---|---|---|
ASPHD1 CRISPR Activationプラスミド (h) | sc-415187-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
ASPHD1 CRISPR Activationプラスミド (h2) | sc-415187-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
ASPHD1 Lentiviral Activation Particles (h) | sc-415187-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
ASPHD1 Lentiviral Activation Particles (h2) | sc-415187-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
ASPHD1 CRISPR Activationプラスミド (m) | sc-433316-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
ASPHD1 CRISPR Activationプラスミド (m2) | sc-433316-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
ASPHD1 Lentiviral Activation Particles (m) | sc-433316-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
ASPHD1 Lentiviral Activation Particles (m2) | sc-433316-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
ASPHD2 CRISPR Activationプラスミド (h) | sc-408926-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
ASPHD2 CRISPR Activationプラスミド (h2) | sc-408926-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
ASPHD2 Lentiviral Activation Particles (h) | sc-408926-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
ASPHD2 Lentiviral Activation Particles (h2) | sc-408926-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
ASPHD2 CRISPR Activationプラスミド (m) | sc-428461-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
ASPHD2 CRISPR Activationプラスミド (m2) | sc-428461-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
ASPHD2 Lentiviral Activation Particles (m) | sc-428461-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
ASPHD2 Lentiviral Activation Particles (m2) | sc-428461-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 |